Increasing value and reducing waste in biomedical research regulation and management

Rustam Al-Shahi Salman, Elaine Beller, Jonathan Kagan, Elina Hemminki, Robert S. Phillips, Julian Savulescu, Malcolm Macleod, Janet Wisely, Iain Chalmers

Research output: Contribution to journalReview articleResearchpeer-review

194 Citations (Scopus)

Abstract

After identifi cation of an important research question and selection of an appropriate study design, waste can arise from the regulation, governance, and management of biomedical research. Obtaining regulatory and governance approval has become increasingly burdensome and disproportionate to the conceivable risks to research participants. Regulation and governance involve interventions that are assumed to be justifi ed in the interests of patients and the public, but they can actually compromise these interests. Ineffi cient management of the procedural conduct of research is wasteful, especially if it results in poor recruitment and retention of participants in well designed studies addressing important questions. These sources of waste can be minimised if the following four recommendations are addressed. First, regulators should use their infl uence to reduce other causes of waste and ineffi ciency in research. Second, regulators and policy makers should work with researchers, patients, and health professionals to streamline and harmonise the laws, regulations, guidelines, and processes that govern whether and how research can be done, and ensure that they are proportionate to the plausible risks associated with the research. Third, researchers and research managers should increase the effi ciency of recruitment, retention, data monitoring, and data sharing in research through use of research designs known to reduce ineffi ciencies, and further research should be done to learn how effi ciency can be increased. Finally, everyone, particularly those responsible for health-care systems, should promote integration of research into everyday clinical practice. Regulators and researchers should monitor adherence to each of these recommendations and publish metrics.

Original languageEnglish
Pages (from-to)176-185
Number of pages10
JournalThe Lancet
Volume383
Issue number9912
DOIs
Publication statusPublished - 2014

Fingerprint

Biomedical Research
Research
Research Personnel
Information Dissemination
Administrative Personnel
Cations
Research Design
Guidelines
Delivery of Health Care
Health

Cite this

Al-Shahi Salman, R., Beller, E., Kagan, J., Hemminki, E., Phillips, R. S., Savulescu, J., ... Chalmers, I. (2014). Increasing value and reducing waste in biomedical research regulation and management. The Lancet, 383(9912), 176-185. https://doi.org/10.1016/S0140-6736(13)62297-7
Al-Shahi Salman, Rustam ; Beller, Elaine ; Kagan, Jonathan ; Hemminki, Elina ; Phillips, Robert S. ; Savulescu, Julian ; Macleod, Malcolm ; Wisely, Janet ; Chalmers, Iain. / Increasing value and reducing waste in biomedical research regulation and management. In: The Lancet. 2014 ; Vol. 383, No. 9912. pp. 176-185.
@article{1226d39b576e4d16b547db058536de80,
title = "Increasing value and reducing waste in biomedical research regulation and management",
abstract = "After identifi cation of an important research question and selection of an appropriate study design, waste can arise from the regulation, governance, and management of biomedical research. Obtaining regulatory and governance approval has become increasingly burdensome and disproportionate to the conceivable risks to research participants. Regulation and governance involve interventions that are assumed to be justifi ed in the interests of patients and the public, but they can actually compromise these interests. Ineffi cient management of the procedural conduct of research is wasteful, especially if it results in poor recruitment and retention of participants in well designed studies addressing important questions. These sources of waste can be minimised if the following four recommendations are addressed. First, regulators should use their infl uence to reduce other causes of waste and ineffi ciency in research. Second, regulators and policy makers should work with researchers, patients, and health professionals to streamline and harmonise the laws, regulations, guidelines, and processes that govern whether and how research can be done, and ensure that they are proportionate to the plausible risks associated with the research. Third, researchers and research managers should increase the effi ciency of recruitment, retention, data monitoring, and data sharing in research through use of research designs known to reduce ineffi ciencies, and further research should be done to learn how effi ciency can be increased. Finally, everyone, particularly those responsible for health-care systems, should promote integration of research into everyday clinical practice. Regulators and researchers should monitor adherence to each of these recommendations and publish metrics.",
author = "{Al-Shahi Salman}, Rustam and Elaine Beller and Jonathan Kagan and Elina Hemminki and Phillips, {Robert S.} and Julian Savulescu and Malcolm Macleod and Janet Wisely and Iain Chalmers",
year = "2014",
doi = "10.1016/S0140-6736(13)62297-7",
language = "English",
volume = "383",
pages = "176--185",
journal = "Lancet",
issn = "0140-6736",
publisher = "Elsevier",
number = "9912",

}

Al-Shahi Salman, R, Beller, E, Kagan, J, Hemminki, E, Phillips, RS, Savulescu, J, Macleod, M, Wisely, J & Chalmers, I 2014, 'Increasing value and reducing waste in biomedical research regulation and management' The Lancet, vol. 383, no. 9912, pp. 176-185. https://doi.org/10.1016/S0140-6736(13)62297-7

Increasing value and reducing waste in biomedical research regulation and management. / Al-Shahi Salman, Rustam; Beller, Elaine; Kagan, Jonathan; Hemminki, Elina; Phillips, Robert S.; Savulescu, Julian; Macleod, Malcolm; Wisely, Janet; Chalmers, Iain.

In: The Lancet, Vol. 383, No. 9912, 2014, p. 176-185.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Increasing value and reducing waste in biomedical research regulation and management

AU - Al-Shahi Salman, Rustam

AU - Beller, Elaine

AU - Kagan, Jonathan

AU - Hemminki, Elina

AU - Phillips, Robert S.

AU - Savulescu, Julian

AU - Macleod, Malcolm

AU - Wisely, Janet

AU - Chalmers, Iain

PY - 2014

Y1 - 2014

N2 - After identifi cation of an important research question and selection of an appropriate study design, waste can arise from the regulation, governance, and management of biomedical research. Obtaining regulatory and governance approval has become increasingly burdensome and disproportionate to the conceivable risks to research participants. Regulation and governance involve interventions that are assumed to be justifi ed in the interests of patients and the public, but they can actually compromise these interests. Ineffi cient management of the procedural conduct of research is wasteful, especially if it results in poor recruitment and retention of participants in well designed studies addressing important questions. These sources of waste can be minimised if the following four recommendations are addressed. First, regulators should use their infl uence to reduce other causes of waste and ineffi ciency in research. Second, regulators and policy makers should work with researchers, patients, and health professionals to streamline and harmonise the laws, regulations, guidelines, and processes that govern whether and how research can be done, and ensure that they are proportionate to the plausible risks associated with the research. Third, researchers and research managers should increase the effi ciency of recruitment, retention, data monitoring, and data sharing in research through use of research designs known to reduce ineffi ciencies, and further research should be done to learn how effi ciency can be increased. Finally, everyone, particularly those responsible for health-care systems, should promote integration of research into everyday clinical practice. Regulators and researchers should monitor adherence to each of these recommendations and publish metrics.

AB - After identifi cation of an important research question and selection of an appropriate study design, waste can arise from the regulation, governance, and management of biomedical research. Obtaining regulatory and governance approval has become increasingly burdensome and disproportionate to the conceivable risks to research participants. Regulation and governance involve interventions that are assumed to be justifi ed in the interests of patients and the public, but they can actually compromise these interests. Ineffi cient management of the procedural conduct of research is wasteful, especially if it results in poor recruitment and retention of participants in well designed studies addressing important questions. These sources of waste can be minimised if the following four recommendations are addressed. First, regulators should use their infl uence to reduce other causes of waste and ineffi ciency in research. Second, regulators and policy makers should work with researchers, patients, and health professionals to streamline and harmonise the laws, regulations, guidelines, and processes that govern whether and how research can be done, and ensure that they are proportionate to the plausible risks associated with the research. Third, researchers and research managers should increase the effi ciency of recruitment, retention, data monitoring, and data sharing in research through use of research designs known to reduce ineffi ciencies, and further research should be done to learn how effi ciency can be increased. Finally, everyone, particularly those responsible for health-care systems, should promote integration of research into everyday clinical practice. Regulators and researchers should monitor adherence to each of these recommendations and publish metrics.

UR - http://www.scopus.com/inward/record.url?scp=84892148591&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(13)62297-7

DO - 10.1016/S0140-6736(13)62297-7

M3 - Review article

VL - 383

SP - 176

EP - 185

JO - Lancet

JF - Lancet

SN - 0140-6736

IS - 9912

ER -

Al-Shahi Salman R, Beller E, Kagan J, Hemminki E, Phillips RS, Savulescu J et al. Increasing value and reducing waste in biomedical research regulation and management. The Lancet. 2014;383(9912):176-185. https://doi.org/10.1016/S0140-6736(13)62297-7